Safety of Venous Thromboembolism Pharmacological Prophylaxis in Hospitalized Patients With Inflammatory Bowel Disease (VISCOUS Study)

Our findings suggest that there is no increased risk of bleeding in patients admitted with IBD exacerbation receiving pharmacological VTE prophylaxis during the admission period. However, prospective data, including high-risk patients (e.g., patients with cancer and pregnant women), is warranted.